NCT02192164View on ClinicalTrials.gov

Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis

CompletedOBSERVATIONAL
Enrollment

126

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Plaque Psoriasis
Interventions
BEHAVIORAL

smoking questionnaire

patients fill in a smoking questionnaire about their smoking habits

Trial Locations (8)

3529

Semmelweis Korhaz-Rendelointezet, Miskolc

4032

Debreceni Egyetem Orvos- es Egeszsegtudomanyi Centrum/Bor- es Nemikortani Klinika, Debrecen

6000

Bacs-Kiskun Megyei Onkormanyzat Korhaza Szegedi Tudomanyegyetem AOK Oktato Korhaza, Kecskemét

6720

Medical University of Szeged, Szeged

9700

Vas Megyei Markusovszky Korhaz/Borgyogyaszati Osztaly, Szombathely

H-1085

Semmelweis University, Budapest

H-7400

Somogy Megyei Kaposi Mór Oktató Kórház, Kaposvár

H-7624

Pecsi Tudomanyegyetem, Br-, Nemikortani es Onkodermatologiai Klinika, Pécs

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02192164 - Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis | Biotech Hunter | Biotech Hunter